<!DOCTYPE html>
<html lang="en">
    <head>
        <title>displaCy</title>
    </head>

    <body style="font-size: 16px; font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Helvetica, Arial, sans-serif, 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol'; padding: 4rem 2rem; direction: ltr">
<figure style="margin-bottom: 6rem">
<div class="entities" style="line-height: 2.5; direction: ltr">%%%%%%%%%%NEW-RECORD%%%%%%%%%% &quot;Discharge summary&quot; &quot;Report&quot;</br>47459,24127,113340,2132-11-29,,,&quot;Discharge summary&quot;,&quot;Report&quot;,,,&quot;Admission Date:  [**2132-11-27**]              Discharge Date:   [**2132-11-29**]</br></br></br>Service: MEDICINE</br></br>Allergies:</br>Patient recorded as having No Known Allergies to Drugs</br></br>Attending:[**First Name3 (LF) 905**]</br>Chief Complaint:</br>chest pain</br></br>Major Surgical or Invasive Procedure:</br>none</br></br></br>History of Present Illness:</br>88 F w/ severe Alzheimer's dementia, CAD w/ severe anterior</br>reversible defects on MIBI in '[**29**] on medical management, now w/</br>rest pain and ECG changes. Per daughter (HCP) pt is not an</br>invasive candidate and DNR/DNI. In [**Name (NI) **], pt recieved 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    asprin
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 
<mark class="entity" style="background: #e89ff0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    325
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">STRENGTH</span>
</mark>
</br>and 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    heparin
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 
<mark class="entity" style="background: #6e31ac; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    gtt
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ROUTE</span>
</mark>
.</br>.</br>Currently, pt feels well and denies SSCP or SOB.</br></br>Past Medical History:</br>1. AD</br>2. HTN</br>3. Chronic anemia, + thal trait</br>4. CAD, + angina, stress test [**4-18**] w/ ischemic EKG changes w/o</br>angina, mild reversible perfusion defect at apex and entire</br>anterior wall, EF approx 60%, fam decided for med treatment</br>only.</br>5. S/p chole</br>6. S/p appy</br>7. S/p facelift</br>8. psoriasis</br>9. S/p B cataract [**Doctor First Name **]</br></br>Social History:</br>Lives with daughter.</br>[**Name (NI) 6934**] without assistance.</br>Distant tobacco.</br>No etoh.</br>She is a retired nurse's aid.</br></br></br>Family History:</br>m- dm</br>f- asthma</br></br></br>Physical Exam:</br>AF 78 104/65 14 98%RA</br>Gen: NAD, A&amp;O X 3</br>Heent: EOMI, PERRL, MMM</br>Neck: JVP ~7cm H20</br>Heart: RRR no mr. + S4</br>Lungs: Clear, no crackles</br>Abd: Benign</br>Ext: No edema, warm extremities, 1+ dp/pt's bilateral.</br></br></br>Pertinent Results:</br>Hematology:</br>[**2132-11-27**] 04:00PM BLOOD WBC-7.0 RBC-4.93 Hgb-10.4* Hct-30.6*</br>MCV-62* MCH-21.2* MCHC-34.1 RDW-13.9 Plt Ct-280</br>[**2132-11-27**] 04:00PM BLOOD PT-11.6 PTT-23.1 INR(PT)-1.0</br>.</br>Chemistry:</br>[**2132-11-27**] 04:00PM BLOOD Glucose-101 UreaN-17 Creat-1.1 Na-137</br>K-4.8 Cl-101 HCO3-28 AnGap-13</br>[**2132-11-27**] 04:00PM BLOOD CK(CPK)-29</br>[**2132-11-28**] 12:35AM BLOOD CK(CPK)-26</br>[**2132-11-28**] 07:35AM BLOOD CK(CPK)-29</br>[**2132-11-29**] 07:30AM BLOOD CK(CPK)-34</br>[**2132-11-27**] 03:59PM BLOOD cTropnT-&lt;0.01</br>[**2132-11-27**] 04:00PM BLOOD CK-MB-2</br>[**2132-11-28**] 12:35AM BLOOD CK-MB-NotDone cTropnT-&lt;0.01</br>[**2132-11-28**] 07:35AM BLOOD CK-MB-3 cTropnT-&lt;0.01</br>[**2132-11-29**] 07:30AM BLOOD CK-MB-NotDone cTropnT-LESS THAN</br>.</br>ECG: NSR, 2mm STE in aVR, diffuse ST depressions and TWI</br>including II, aVF, V3-V6. LAFB. No STE in V4R. No ST depressions</br>in V7-V9.</br>.</br>CXR: Clear.</br>.</br></br></br>Brief Hospital Course:</br>87 yo fem c alzheimer's disease, known uncontrolled HTN and</br>known CAD now p/w ACS and ECG worrisome for diffuse</br>subendocardial ischemia.</br>.</br># CAD/ISchemia: ECG shows diffuse subendocardial ischemia with</br>elevation in aVR and diffuse ST depressions. Spoke to daughter</br>(HCP) today and risks/benefits of cardiac catheterization were</br>discussed in depth. Daughter feels medical management is</br>appropriate. Patient was initially chest pain free but did</br>develop episodic chest pain relieved with 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    nitroglycerin
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
. Treated</br>with no intention for interventional procedure unless SSCP</br>becomes incessant. She was continued on 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ASA
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
/
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    plavix
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
/
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    BB
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
/
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    statin
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
.</br>
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Heparin
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 
<mark class="entity" style="background: #6e31ac; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    gtt
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ROUTE</span>
</mark>
 was discontinued after it was determined that there</br>would be no intervention. She was successfully weaned from the</br>
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    nitro
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 
<mark class="entity" style="background: #6e31ac; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    gtt
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ROUTE</span>
</mark>
. She was started on 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    isordil
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 which her BP tolerated</br>well.</br>.</br>#Pump: Euvolemic. Borderline normal BP. Held 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ACE
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG-VERY NON TRIVIAL</span>
</mark>
 intially to</br>leave room for 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    BB
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
/
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    nitro
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
.</br>.</br># Rhythm: NSR, no issues.</br>.</br># Anemia: Previous records show Hb EP c/w Thalassemia trait as</br>well as iron deficiency. Fe/TIBC 15.7% with ferritin of 47 in</br>[**1-20**]. She was continued on 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    iron supplements
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 with 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    ascorbic acid
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
</br>while on 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PPI
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
. Her hematocrit remained low but stable.</br>.</br># Dementia: Advanced dementia although still alert and very</br>pleasant.</br></br></br>Medications on Admission:</br>1. 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Metoprolol Tartrate
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 
<mark class="entity" style="background: #e89ff0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    50 mg
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">STRENGTH</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 Sig: 
<mark class="entity" style="background: #78b98f; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    One (1)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DOSAGE</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 
<mark class="entity" style="background: #6e31ac; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PO
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ROUTE</span>
</mark>
 
<mark class="entity" style="background: #c7c2ec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    BID
(2 times a day)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FREQUENCY</span>
</mark>
.</br>2. 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Captopril
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 
<mark class="entity" style="background: #e89ff0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    12.5 mg
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">STRENGTH</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 Sig: 
<mark class="entity" style="background: #78b98f; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    One (1)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DOSAGE</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 
<mark class="entity" style="background: #6e31ac; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PO
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ROUTE</span>
</mark>
 
<mark class="entity" style="background: #c7c2ec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    BID (2 times
a day)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FREQUENCY</span>
</mark>
.</br>3. 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Aspirin
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 
<mark class="entity" style="background: #e89ff0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    81 mg
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">STRENGTH</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet, Delayed Release (E.C.)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 Sig: 
<mark class="entity" style="background: #78b98f; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    One (1)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DOSAGE</span>
</mark>
</br>
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet, Delayed Release (E.C.)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 
<mark class="entity" style="background: #6e31ac; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PO
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ROUTE</span>
</mark>
 
<mark class="entity" style="background: #c7c2ec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DAILY (Daily)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FREQUENCY</span>
</mark>
.</br>4. 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Hexavitamin
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
     
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 Sig: 
<mark class="entity" style="background: #78b98f; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    One (1)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DOSAGE</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Cap
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 
<mark class="entity" style="background: #6e31ac; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PO
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ROUTE</span>
</mark>
 
<mark class="entity" style="background: #c7c2ec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DAILY (Daily)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FREQUENCY</span>
</mark>
.</br>5. 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Nitroglycerin
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 
<mark class="entity" style="background: #e89ff0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    0.4 mg
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">STRENGTH</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet, Sublingual
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 Sig: 
<mark class="entity" style="background: #78b98f; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    One (1)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DOSAGE</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet,
Sublingual
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 
<mark class="entity" style="background: #6e31ac; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Sublingual
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ROUTE</span>
</mark>
 
<mark class="entity" style="background: #c7c2ec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PRN (as needed) as needed
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FREQUENCY</span>
</mark>
 for chest pain.</br>6. 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Ferrous Sulfate
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 
<mark class="entity" style="background: #e89ff0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    325 (65) mg
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">STRENGTH</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 Sig: 
<mark class="entity" style="background: #78b98f; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    One (1)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DOSAGE</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 
<mark class="entity" style="background: #6e31ac; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PO
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ROUTE</span>
</mark>
</br>
<mark class="entity" style="background: #c7c2ec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DAILY (Daily)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FREQUENCY</span>
</mark>
.</br>7. 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Furosemide
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 
<mark class="entity" style="background: #e89ff0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    20 mg
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">STRENGTH</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 Sig: 
<mark class="entity" style="background: #78b98f; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    One (1)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DOSAGE</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 
<mark class="entity" style="background: #6e31ac; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PO
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ROUTE</span>
</mark>
 
<mark class="entity" style="background: #c7c2ec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DAILY (Daily)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FREQUENCY</span>
</mark>
.</br></br>8. 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Atorvastatin
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 
<mark class="entity" style="background: #e89ff0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    80 mg
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">STRENGTH</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 Sig: 
<mark class="entity" style="background: #78b98f; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    One (1)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DOSAGE</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 
<mark class="entity" style="background: #6e31ac; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PO
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ROUTE</span>
</mark>
 
<mark class="entity" style="background: #c7c2ec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DAILY
(Daily)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FREQUENCY</span>
</mark>
.</br>Disp:*30 Tablet(s)* Refills:*0*</br>9. 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Isosorbide Dinitrate
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 
<mark class="entity" style="background: #e89ff0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    10 mg
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">STRENGTH</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 Sig: 
<mark class="entity" style="background: #78b98f; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Two (2)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DOSAGE</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 
<mark class="entity" style="background: #6e31ac; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PO
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ROUTE</span>
</mark>
 
<mark class="entity" style="background: #c7c2ec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    TID
(3 times a day)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FREQUENCY</span>
</mark>
.</br>Disp:*180 Tablet(s)* Refills:*0*</br>10. 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Prilosec
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 OTC 
<mark class="entity" style="background: #e89ff0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    20 mg
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">STRENGTH</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet, Delayed Release (E.C.)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 Sig: 
<mark class="entity" style="background: #78b98f; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    One

    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DOSAGE</span>
</mark>
(1) 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet, Delayed Release (E.C.)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 
<mark class="entity" style="background: #6e31ac; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PO
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ROUTE</span>
</mark>
 
<mark class="entity" style="background: #c7c2ec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    once a day
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FREQUENCY</span>
</mark>
.</br></br></br>Discharge Medications:</br>1. 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Aspirin
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 
<mark class="entity" style="background: #e89ff0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    325 mg
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">STRENGTH</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 Sig: 
<mark class="entity" style="background: #78b98f; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    One (1)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DOSAGE</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 
<mark class="entity" style="background: #6e31ac; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PO
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ROUTE</span>
</mark>
 
<mark class="entity" style="background: #c7c2ec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DAILY (Daily)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FREQUENCY</span>
</mark>
.</br>2. 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Atorvastatin
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 
<mark class="entity" style="background: #e89ff0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    80 mg
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">STRENGTH</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 Sig: 
<mark class="entity" style="background: #78b98f; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    One (1)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DOSAGE</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 
<mark class="entity" style="background: #6e31ac; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PO
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ROUTE</span>
</mark>
 
<mark class="entity" style="background: #c7c2ec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DAILY
(Daily)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FREQUENCY</span>
</mark>
.</br>3. 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Clopidogrel
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 
<mark class="entity" style="background: #e89ff0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    75 mg
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">STRENGTH</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 Sig: 
<mark class="entity" style="background: #78b98f; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    One (1)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DOSAGE</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 
<mark class="entity" style="background: #6e31ac; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PO
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ROUTE</span>
</mark>
 
<mark class="entity" style="background: #c7c2ec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DAILY
(Daily)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FREQUENCY</span>
</mark>
.</br>Disp:*30 Tablet(s)* Refills:*2*</br>4. 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Metoprolol Tartrate
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 
<mark class="entity" style="background: #e89ff0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    50 mg
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">STRENGTH</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 Sig: 
<mark class="entity" style="background: #78b98f; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    One (1)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DOSAGE</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 
<mark class="entity" style="background: #6e31ac; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PO
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ROUTE</span>
</mark>
 
<mark class="entity" style="background: #c7c2ec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    TID
(3 times a day)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FREQUENCY</span>
</mark>
.</br>5. 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Furosemide
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 
<mark class="entity" style="background: #e89ff0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    20 mg
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">STRENGTH</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 Sig: 
<mark class="entity" style="background: #78b98f; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    One (1)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DOSAGE</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 
<mark class="entity" style="background: #6e31ac; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PO
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ROUTE</span>
</mark>
 
<mark class="entity" style="background: #c7c2ec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DAILY (Daily)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FREQUENCY</span>
</mark>
.</br></br>6. 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Ferrous Sulfate
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 
<mark class="entity" style="background: #e89ff0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    325 (65) mg
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">STRENGTH</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 Sig: 
<mark class="entity" style="background: #78b98f; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    One (1)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DOSAGE</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 
<mark class="entity" style="background: #6e31ac; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PO
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ROUTE</span>
</mark>
</br>
<mark class="entity" style="background: #c7c2ec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    DAILY (Daily)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FREQUENCY</span>
</mark>
.</br>7. 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Ascorbic Acid
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 
<mark class="entity" style="background: #e89ff0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    500 mg
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">STRENGTH</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 Sig: 
<mark class="entity" style="background: #78b98f; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    One (1)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DOSAGE</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 
<mark class="entity" style="background: #6e31ac; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PO
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ROUTE</span>
</mark>
 
<mark class="entity" style="background: #c7c2ec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    once
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FREQUENCY</span>
</mark>
 a</br>day.</br>8. 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Omeprazole
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 
<mark class="entity" style="background: #e89ff0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    20 mg
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">STRENGTH</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Capsule, Delayed Release(E.C.)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 Sig: 
<mark class="entity" style="background: #78b98f; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    One (1)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DOSAGE</span>
</mark>
</br>
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Capsule, Delayed Release(E.C.)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 
<mark class="entity" style="background: #6e31ac; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PO
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ROUTE</span>
</mark>
 
<mark class="entity" style="background: #c7c2ec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    once a day
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FREQUENCY</span>
</mark>
.</br>9. 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Captopril
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 
<mark class="entity" style="background: #e89ff0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    12.5 mg
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">STRENGTH</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 Sig: 
<mark class="entity" style="background: #78b98f; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    One (1)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DOSAGE</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 
<mark class="entity" style="background: #6e31ac; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PO
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ROUTE</span>
</mark>
 
<mark class="entity" style="background: #c7c2ec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    BID (2 times
a day)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FREQUENCY</span>
</mark>
.</br>10. 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Isosorbide Dinitrate
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 
<mark class="entity" style="background: #e89ff0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    10 mg
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">STRENGTH</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 Sig: 
<mark class="entity" style="background: #78b98f; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Three (3)
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DOSAGE</span>
</mark>
 
<mark class="entity" style="background: #34466d; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Tablet
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FORM</span>
</mark>
 
<mark class="entity" style="background: #6e31ac; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    PO
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ROUTE</span>
</mark>
</br>
<mark class="entity" style="background: #c7c2ec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    three times a day
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FREQUENCY</span>
</mark>
.</br>Disp:*270 Tablet(s)* Refills:*2*</br></br></br>Discharge Disposition:</br>Home</br></br>Discharge Diagnosis:</br>primary: unstable angina</br>.</br>secondary:</br>alzheimers disease</br>hypertension</br>chronic anemia with thalassemia trait</br>coronary artery disease</br>status-post cholecystectomy</br>status-post appendectomy</br>status-post facelift</br>psoriasis</br>status-post bilateral cataract surgery</br></br></br>Discharge Condition:</br>good</br></br></br>Discharge Instructions:</br>Weigh yourself every morning, [**Name8 (MD) 138**] MD if weight &gt; 3 lbs.</br>Adhere to 2 gm sodium diet</br>Fluid Restriction: 2000ml</br>.</br>Please take all medications as prescribed.</br>.</br>Changed medications: 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    imdur
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
</br>.</br>If you experience worsening chest pain, shortness of breath,</br>nausea, vomiting, dizziness, or other concerning symptoms call</br>your doctor or return to the Emergency Department immediately.</br></br>Followup Instructions:</br>You are scheduled for the following appointments. Please contact</br>the [**Name2 (NI) 11686**] provider with any questions or if you need to</br>reschedule.</br>.</br>Provider: [**Name10 (NameIs) **],[**First Name8 (NamePattern2) 2352**] [**Last Name (NamePattern1) 2352**] - ADULT MEDICINE (SB)</br>Date/Time:[**2132-12-11**] 11:30</br></br></br>                             [**Name6 (MD) 251**] [**Name8 (MD) **] MD [**MD Number(1) 910**]</br></br>&quot;</br></br>%%%%%%%%%%NEW-RECORD%%%%%%%%%% &quot;Discharge summary&quot; &quot;Report&quot;</br>47460,24127,113340,2132-11-30,,,&quot;Discharge summary&quot;,&quot;Report&quot;,,,&quot;Admission Date:  [**2132-11-30**]              Discharge Date:   [**2132-11-30**]</br></br></br>Service: MEDICINE</br></br>Allergies:</br>Patient recorded as having No Known Allergies to Drugs</br></br>Attending:[**First Name3 (LF) 134**]</br>Chief Complaint:</br>STEMI, s/p stent to RCA, LAD</br></br>Major Surgical or Invasive Procedure:</br>Endotracheal intubation</br>Central line placement</br>Cardiac catherization</br>Intra-aortic balloon pump placement</br>Cardiac defibrillation for PEA arrest</br></br></br>History of Present Illness:</br>88 F w/ severe Alzheimer's dementia, CAD w/ severe anterior</br>reversible defects on MIBI in '[**29**] on medical management, now w/</br>rest pain and ECG changes. Chest pain not responsive to 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    NTG
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
, EKG</br>wwith ST elevations in avR, global ST depressions v2-v6,I, avL.</br>In cath lab, pt had PEA arrest for approximately 20 minutes, was</br>intubated, and had CPR. RCA was stented, placed on 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    dopamine
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
,</br>
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    levophed
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 
<mark class="entity" style="background: #6e31ac; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    gtts
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">ROUTE</span>
</mark>
, and 
<mark class="entity" style="background: #ff8000; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    IABP
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG - FALSE POSITIVE</span>
</mark>
 for BP support to maintain MAP&gt;60. Left</br>main thrombotic with heavy calcification, distal occlusion, LAD</br>proximal occlusion, minimal left circumflex disease, 90%</br>occlusion in RCA s/p PCI LM-&gt;Lcx, RCA. LAD could not be</br>assessed. CI 2.16, MAP 69, PCWP 13, PA 32/22, RV 31/10.</br></br>Past Medical History:</br>1. AD</br>2. HTN</br>3. Chronic anemia, + thal trait</br>4. CAD, + angina, stress test [**4-18**] w/ ischemic EKG changes w/o</br>angina, mild reversible perfusion defect at apex and entire</br>anterior wall, EF approx 60%, fam decided for med treatment</br>only.</br>5. S/p chole</br>6. S/p appy</br>7. S/p facelift</br>8. psoriasis</br>9. S/p B cataract [**Doctor First Name **]</br></br>Social History:</br>Lives with daughter.</br>[**Name (NI) 6934**] without assistance.</br>Distant tobacco.</br>No etoh.</br>She is a retired nurse's aid.</br></br></br>Family History:</br>m- dm</br>f- asthma</br></br></br>Physical Exam:</br>T 92.5 HR 122 BP 101/76 on mechanical ventilation</br>Gen: sedated, ETT in place</br>Heent: doll's eye negative, pupils [**4-17**] bilaterally, corneal</br>reflex present in R, not in L eye</br>Neck: JVP ~7cm H20</br>Heart: sinus bradycardia, no rubs/gallops, no murmurs</br>Lungs: positive breath sounds bilaterally, no crackles</br>Abd: non-distended, hypoactive bowel sounds</br>Ext: No edema, warm extremities, pulses dopplerable</br></br></br>Pertinent Results:</br>[**2132-11-30**] 08:08PM   O2 SAT-55</br>[**2132-11-30**] 07:55PM   GLUCOSE-147* UREA N-16 CREAT-1.3* SODIUM-139</br>POTASSIUM-4.8 CHLORIDE-111* TOTAL CO2-8* ANION GAP-25*</br>[**2132-11-30**] 07:55PM   MAGNESIUM-2.5</br>[**2132-11-30**] 06:52PM   TYPE-ART TEMP-36.7 RATES-21/10 TIDAL VOL-500</br>PEEP-5 O2-80 PO2-78* PCO2-23* PH-7.12* TOTAL CO2-8* BASE XS--20</br>AADO2-484 REQ O2-80 -ASSIST/CON INTUBATED-INTUBATED</br>[**2132-11-30**] 06:52PM   GLUCOSE-161*</br>[**2132-11-30**] 06:41PM   POTASSIUM-4.5</br>[**2132-11-30**] 06:41PM   CK(CPK)-1124*</br>[**2132-11-30**] 06:41PM   CK-MB-118* MB INDX-10.5*</br>[**2132-11-30**] 06:41PM   HCT-34.5*</br>[**2132-11-30**] 06:41PM   PLT COUNT-171</br>[**2132-11-30**] 04:03PM   O2 SAT-40</br>[**2132-11-30**] 04:01PM   TYPE-ART TEMP-35.4 TIDAL VOL-480 PEEP-5</br>O2-100 PO2-150* PCO2-30* PH-7.18* TOTAL CO2-12* BASE XS--15</br>AADO2-551 REQ O2-89 -ASSIST/CON INTUBATED-INTUBATED</br>[**2132-11-30**] 04:01PM   O2 SAT-98</br>[**2132-11-30**] 03:32PM   HCT-33.2*#</br>[**2132-11-30**] 03:32PM   PLT COUNT-197</br>[**2132-11-30**] 03:32PM   PT-16.5* PTT-81.1* INR(PT)-1.5*</br>[**2132-11-30**] 01:38PM   TYPE-ART TIDAL VOL-500 PEEP-5 O2-100 PO2-104</br>PCO2-36 PH-7.16* TOTAL CO2-14* BASE XS--15 AADO2-591 REQ O2-95</br>-ASSIST/CON INTUBATED-INTUBATED</br>[**2132-11-30**] 12:33PM   O2 SAT-50</br>[**2132-11-30**] 12:25PM   TYPE-ART RATES-18/ TIDAL VOL-500 O2-100</br>PO2-118* PCO2-46* PH-7.12* TOTAL CO2-16* BASE XS--14 AADO2-567</br>REQ O2-91 INTUBATED-INTUBATED VENT-CONTROLLED</br>[**2132-11-30**] 12:25PM   LACTATE-6.9*</br>[**2132-11-30**] 12:25PM   O2 SAT-96</br>[**2132-11-30**] 12:12PM   GLUCOSE-313* UREA N-15 CREAT-0.9 SODIUM-137</br>POTASSIUM-3.3 CHLORIDE-110* TOTAL CO2-12* ANION GAP-18</br>[**2132-11-30**] 12:12PM   ALT(SGPT)-167* AST(SGOT)-250* LD(LDH)-441*</br>CK(CPK)-333* ALK PHOS-53 TOT BILI-0.5</br>[**2132-11-30**] 12:12PM   CK-MB-25* MB INDX-7.5* cTropnT-1.05*</br>[**2132-11-30**] 12:12PM   CALCIUM-5.4* PHOSPHATE-5.0* MAGNESIUM-1.6</br>[**2132-11-30**] 12:12PM   WBC-17.9*# RBC-3.07*# HGB-6.5*# HCT-20.3*#</br>MCV-66* MCH-21.3* MCHC-32.2 RDW-14.5</br>[**2132-11-30**] 12:12PM   PLT COUNT-236</br>[**2132-11-30**] 12:12PM   PT-17.2* PTT-150* INR(PT)-1.6*</br>[**2132-11-30**] 10:23AM   TYPE-ART PO2-67* PCO2-49* PH-7.21* TOTAL</br>CO2-21 BASE XS--8</br>[**2132-11-30**] 06:39AM   PLT COUNT-296</br>[**2132-11-30**] 06:39AM   PT-11.8 PTT-23.2 INR(PT)-1.0</br>[**2132-11-29**] 03:00PM   HCT-31.2*</br>[**2132-11-29**] 07:30AM   GLUCOSE-89 UREA N-17 CREAT-1.0 SODIUM-137</br>POTASSIUM-4.1 CHLORIDE-103 TOTAL CO2-26 ANION GAP-12</br>[**2132-11-29**] 07:30AM   CK(CPK)-34</br>[**2132-11-29**] 07:30AM   CK-MB-NotDone cTropnT-LESS THAN</br>[**2132-11-29**] 07:30AM   MAGNESIUM-2.1</br>[**2132-11-29**] 07:30AM   WBC-7.4 RBC-4.33 HGB-9.4* HCT-27.0* MCV-62*</br>MCH-21.6* MCHC-34.7 RDW-13.9</br>.</br>ECG Study Date of [**2132-11-29**]  7:53:00 AM</br>Sinus rhythm with atrial premature depolarizations.</br>Non-diagnostic</br>repolarization abnormalities. Borderline first degree</br>atrio-ventricular</br>conduction delay. Compared to the previous tracing of [**2132-11-28**]</br>no diagnostic</br>change.</br>.</br>CHEST (PORTABLE AP)  [**2132-11-30**] 6:22 PM</br>Nasogastric tube has been removed. Swan-Ganz catheter has been</br>slightly advanced and now terminates in the left infrahilar</br>region and could be withdrawn a few centimeters for more optimal</br>positioning. Cardiac silhouette is stable in size. Central</br>perihilar and basilar pattern of alveolar pulmonary edema is</br>minimally improved, and there is persistent diffuse septal</br>thickening consistent with interstitial component of edema.</br>.</br>Increased lucency is noted at the extreme right costophrenic</br>sulcus, concerning for possible basilar pneumothorax on this</br>supine radiograph. Additional left lateral decubitus radiograph</br>of the right lung may be helpful to confirm or exclude this</br>possibility as communicated by telephone to Dr. [**Last Name (STitle) 1611**] on [**11-30**], [**2132**].</br>.</br>C.CATH Study Date of [**2132-11-30**]</br>COMMENTS:</br>1. Selective coronary angiography demonstrated a severe left</br>main and</br>three vessel coronary disease.  The LMCA had a thrombotic distal</br></br>occlusion with heavy calcification.  The LAD was occluded</br>proximally</br>with faint collaterals from the RCA.  The Lcx was a non-dominant</br>vessel</br>with a RI.  It had a proximal 99% stenosis with a TIMI I flow</br>distally.</br>The RCA was a dominant vesse; with an 80% stenosis proximally</br>and a</br>mid-segment calcified 90% stenosis distally.</br>2. Resting hemodynamics revealed a borderline elevated PCWP of</br>13 mm Hg,</br>and a cardiac index of 2.16 l/min/m2 on 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    dopamine
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 and 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    levophed
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
.</br>3. The RLE had a retrograde dissection in REIA, without</br>compromise on</br>flow.</br>4. Patient had a PEA arrest during an attempt to cross the LMCA</br>thrombotic lesion; CPR was applied with a good resulting blood</br>pressure</br>and resumption of spontaneous cardiac activity.</br>.</br>FINAL DIAGNOSIS:</br>1. Thrombotic distal left main and severe three vessel coronary</br>artery</br>disease.</br>2. Acute anterior myocardial infarction managed by acute PTCA of</br>LMCA-RI</br>and IABP placement.</br>3. Cardiogenic shock.</br>4. Retrograde dissection in REIA without flow compromise.</br>.</br>ECG Study Date of [**2132-11-30**]  6:15:32 AM</br>Sinus rhythm. Marked ST segment depressions with T wave</br>inversions in the</br>anterolateral precordial leads suggestive of acute anterolateral</br>left</br>ventricular ischemia. Compared to the previous tracing of</br>[**2132-11-29**] acute</br>ischemia now manifest.</br>.</br>ECG Study Date of [**2132-11-30**]  12:40:10 PM</br>Sinus tachycardia. Diffuse ST-T wave changes are suggestive of</br>ischemia.</br>Compared to the previous tracing of [**2132-11-30**] ST-T wave changes</br>are less</br>prominent.</br></br>Brief Hospital Course:</br>88 yo female hx HTN, CAD, s/p LHC for CP w/ distal LM</br>anteriorly, proximal LAD, Lcx, and RCA occlusion s/p stent to LM</br>and RCA in cardiogenic shock on 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    levophed
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
, 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    dopa
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
, and 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    vasopressin
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
,</br>as well as IABP. Transferred to the CCU after cardiac</br>catherization. Patient remained intubated and systolic blood</br>pressures ranged from 70-80s with tachycardia. ABG consistent</br>with severe primary metabolic acidosis. Neurological exam</br>revealed lack of brain stem reflexes with negative doll's eyes,</br>corneal reflex, and gag reflex.</br>.</br>Patient's hemodynamic status continued to deteriorate despite</br>being on three 
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pressors
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
. A hematocrit drop was noted from</br>baseline of 28-30 down to 20. She was transfused 
<mark class="entity" style="background: #78b98f; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    2 units
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DOSAGE</span>
</mark>
 of</br>
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    pRBCs
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 which only slightly increased the BP. UOP continued to</br>decline over the course of 8 hours as patient was making less</br>than 20cc's urine per hour. Vent settings were frequently</br>modified to correct for the metabolic acidosis through</br>respiratory compensation, however, patient was tachypneic and</br>breathing over the vent respirations. pH continued to trend down</br>despite adjusting for PEEP and minute ventilation.</br>.</br>Code status was discussed with the family as patient was full</br>code and had been shocked out of PEA arrest while in the</br>catherization lab prior to transfer. However, the family</br>including the healthcare proxy did not wish for further</br>resuscitation measures such as defibrillation if patient were to</br>arrest again. Patient was made DNR/DNI. She went into PEA arrest</br>in the evening of admission and time of death was 8:28pm. Family</br>chose not to do a post-mortem autopsy.</br></br>Medications on Admission:</br>
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    metoprolol
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 
<mark class="entity" style="background: #e89ff0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    50
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">STRENGTH</span>
</mark>
 [**Hospital1 **]</br>
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    captopril
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 
<mark class="entity" style="background: #e89ff0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    12.5
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">STRENGTH</span>
</mark>
 [**Hospital1 **]</br>
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    asa
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 
<mark class="entity" style="background: #e89ff0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    81
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">STRENGTH</span>
</mark>
 
<mark class="entity" style="background: #c7c2ec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    qd
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FREQUENCY</span>
</mark>
</br>
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    NTG
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 
<mark class="entity" style="background: #c7c2ec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    prn
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FREQUENCY</span>
</mark>
</br>
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    Ferrous sulfate
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 
<mark class="entity" style="background: #e89ff0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    325
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">STRENGTH</span>
</mark>
 
<mark class="entity" style="background: #c7c2ec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    qd
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FREQUENCY</span>
</mark>
</br>
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    lasix
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 
<mark class="entity" style="background: #e89ff0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    20
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">STRENGTH</span>
</mark>
 
<mark class="entity" style="background: #c7c2ec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    qd
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FREQUENCY</span>
</mark>
</br>
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    atorvastatin
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 
<mark class="entity" style="background: #e89ff0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    20
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">STRENGTH</span>
</mark>
 
<mark class="entity" style="background: #c7c2ec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    qd
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FREQUENCY</span>
</mark>
</br>
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    isosorbide
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 
<mark class="entity" style="background: #e89ff0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    20
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">STRENGTH</span>
</mark>
 
<mark class="entity" style="background: #c7c2ec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    tid
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FREQUENCY</span>
</mark>
</br>
<mark class="entity" style="background: #235e31; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    prilosec
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">DRUG</span>
</mark>
 
<mark class="entity" style="background: #e89ff0; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    20
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">STRENGTH</span>
</mark>
 
<mark class="entity" style="background: #c7c2ec; padding: 0.45em 0.6em; margin: 0 0.25em; line-height: 1; border-radius: 0.35em;">
    qd
    <span style="font-size: 0.8em; font-weight: bold; line-height: 1; border-radius: 0.35em; text-transform: uppercase; vertical-align: middle; margin-left: 0.5rem">FREQUENCY</span>
</mark>


Discharge Medications:
None

Discharge Disposition:
Expired

Discharge Diagnosis:
Cardiac arrest- Pulseless electrical activity
.
Other diagnoses:
1. AD
2. HTN
3. Chronic anemia, + thal trait
4. CAD, + angina, stress test [**4-18**] w/ ischemic EKG changes w/o
angina, mild reversible perfusion defect at apex and entire
anterior wall, EF approx 60%, fam decided for med treatment
only.
5. S/p chole
6. S/p appy
7. S/p facelift
8. psoriasis
9. S/p B cataract [**Doctor First Name **]


Discharge Condition:
Expired


Discharge Instructions:
n/a

Followup Instructions:
None



&quot;

</div>
</figure>
</body>
</html>